• X-Gal: Precision Blue-White Colony Screening in Molecular Cl

  2026-05-09

  X-Gal from APExBIO is the trusted standard for high-contrast blue-white colony screening and β-galactosidase reporting, enabling rapid, reproducible detection of recombinant clones. Drawing on recent sensory biology research and validated workflows, this article bridges molecular cloning with innovative applications and offers actionable troubleshooting strategies for consistent results.

• X-Gal in Modern Molecular Cloning: Beyond Blue-White Screeni

  2026-05-09

  Explore the advanced roles of X-Gal (5-bromo-4-chloro-indolyl-β-D-galactopyranoside) in molecular cloning and β-galactosidase assays. This article delivers a deep-dive into mechanisms, assay design, and new scientific insights for maximizing reliability in recombinant DNA technology.

• HSP70 Modulates TDP-43 Condensation in Poly-PR-Induced Stres

  2026-05-08

  Agnihotri et al. elucidate how C9ORF72 poly-PR dipeptides disrupt TDP-43 nuclear condensation via NEAT1, revealing the pivotal role of HSP70 chaperone activity in maintaining condensate dynamics. These findings provide mechanistic insight into ALS/FTD pathology and inform experimental strategies for chaperone-targeted research.

• Comparative Antibacterial Efficacy of N-Formimidoyl Thienamy

  2026-05-07

  This article examines a pivotal comparative study assessing the antibacterial activity of N-formimidoyl thienamycin (MK0787) against a range of resistant clinical isolates, benchmarking its performance alongside recently developed β-lactam antibiotics, including cefoperazone. The findings inform rational selection and design of in vitro antimicrobial assays and highlight the need for nuanced interpretation of β-lactamase stability and spectrum in translational research.

• Etoposide (VP-16): Precision DNA Damage Induction in Cancer

  2026-05-07

  Etoposide (VP-16) is a potent DNA topoisomerase II inhibitor widely used to induce DNA double-strand breaks and apoptosis in cancer cell models. Its variable cytotoxicity, robust solubility in DMSO, and validated efficacy in both in vitro and in vivo systems make it a benchmark compound for DNA damage assays. This article details its mechanism, application limits, and standardized workflow parameters for research.

• Perospirone Inhibits Vascular Kv1.5 Channels: New Off-Target

  2026-05-06

  This study demonstrates that Perospirone, a second-generation antipsychotic, inhibits voltage-gated Kv1.5 potassium channels in coronary arterial smooth muscle cells—an unrecognized off-target effect. These findings expand our understanding of Perospirone’s pharmacology, highlighting implications for both schizophrenia research and cardiovascular safety assessments.

• ML385: Strategic NRF2 Inhibition for Translational Oncology

  2026-05-06

  Explore how ML385, a selective NRF2 inhibitor from APExBIO, enables translational researchers to dissect oxidative stress, therapeutic resistance, and ferroptosis in cancer and liver disease models. This thought-leadership article bridges mechanistic insight, protocol optimization, and strategic guidance for impactful lab-to-clinic research.

• iRhom2 Regulates Olfactory Receptor Expression and Sensory A

  2026-05-05

  Azzopardi et al. (2024) reveal that iRhom2 is uniquely expressed in olfactory sensory neurons and orchestrates odorant receptor gene regulation and activity-dependent adaptation. This work defines a feedback mechanism by which odor exposure modulates iRhom2 and, consequently, olfactory receptor expression, advancing understanding of GPCR-mediated signaling in sensory systems.

• DiI (DiIC18(3)) Plasma Membrane Orange Fluorescent Probe Gui

  2026-05-05

  DiI (DiIC18(3)) Plasma Membrane Orange Fluorescent Probe enables selective, high-contrast labeling of plasma membranes in both live and fixed samples, solving challenges in neuronal tracing and membrane-specific cell assays. It should not be used in protocols requiring aqueous solubility or targeting intracellular organelles, and protocol setup must account for its strict solvent requirements.

• TNFAIP2-Driven Cisplatin Resistance via KEAP1/NRF2 in HNSCC

  2026-05-04

  Xu et al. reveal that TNFAIP2 confers cisplatin (CDDP) resistance in head and neck squamous cell carcinoma (HNSCC) by modulating the KEAP1/NRF2 antioxidant pathway. Their work elucidates a specific molecular axis impacting chemotherapy response, providing potential targets to improve therapeutic efficacy.

• iRhom2 Modulates Olfactory Receptor Regulation and Adaptatio

  2026-05-04

  Azzopardi et al. reveal that iRhom2 is selectively expressed in olfactory sensory neurons and modulates odorant receptor gene regulation via an activity-dependent mechanism involving ADAM17. This work provides new insight into negative feedback processes governing olfactory receptor expression and highlights potential signaling pathways in sensory adaptation.

• ECL Chemiluminescent Substrate Detection Kit: Hypersensitive

  2026-05-03

  Unlock ultrasensitive western blot detection with the ECL Chemiluminescent Substrate Detection Kit (Hypersensitive), designed for low-abundance protein analysis on nitrocellulose and PVDF membranes. This guide demystifies protocol optimization, troubleshooting, and highlights translational use-cases inspired by recent advances in neuronal circuit research.

• TG003 Cdc2-like Kinase Inhibitor: Applied Splicing and Resis

  2026-05-02

  TG003 stands out for its precision in alternative splicing modulation and platinum resistance research, as validated by recent mechanistic studies. This article delivers actionable workflows, troubleshooting strategies, and evidence-based insights, enabling researchers to leverage TG003 for high-impact splice site selection and disease modeling.

• Ultra Fast LC–MS/MS for Simultaneous Quantification of Cefaz

  2026-05-02

  This study introduces and validates an ultra fast liquid chromatography–tandem mass spectrometry (UFLC–MS/MS) method for the simultaneous determination of cefazedone and etimicin in beagle dog plasma. The method enables precise pharmacokinetic studies of combination antibiotic regimens, supporting optimized dosing strategies for serious bacterial infections.

• Ciprofloxacin Hydrochloride: Single-Cell Mechanisms and Rese

  2026-05-01

  Explore how ciprofloxacin hydrochloride, a leading fluoroquinolone antibiotic, uniquely disrupts bacterial DNA replication at the single-cell level. This article reveals advanced mechanisms, assay implications, and immunomodulatory effects not covered elsewhere.

16344 records 1/1090 page Next 12345 下5页 Last page